International Differences in Approaches to 131I Therapy for Graves' Disease: Case Selection and Restrictions Recommended to Patients in Japan, Korea, and China-Reference-Cited by-同舟云学术

International Differences in Approaches to 131I Therapy for Graves' Disease: Case Selection and Restrictions Recommended to Patients in Japan, Korea, and China

Published:1997-04 Issue:2 Volume:7 Page:217-220
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

TOMINAGA TAN,YOKOYAMA NAOKATA,NAGATAKI SHIGENOBU,CHO BO YOUN,KOH CHANG-SOON,CHEN JIA-LUN,SHI YIFAN

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.1997.7.217

Reference4 articles.

1. Current Trends in the Management of Graves' Disease*

2. Differences and Similarities in the Diagnosis and Treatment of Graves' Disease in Europe, Japan, and The United States

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2021 Asia-Pacific Graves’ Disease Consortium Survey of Clinical Practice Patterns in the Management of Graves’ Disease;Endocrine;2022-09-21

2. Treatment of patients with Graves’ disease in Sweden compared to international surveys of an ‘index patient’;Endocrinology, Diabetes & Metabolism;2021-03-16

3. Management of Graves’ Hyperthyroidism: More Than a Century of Progression;International Journal of Endocrinology and Metabolism;2020-06-27

4. Diagnosis and Management of Graves’ Disease in Thailand: A Survey of Current Practice;Journal of Thyroid Research;2020-05-11

5. Management of Thyrotoxicosis Among General Practitioners in Trinidad Compared with 2016 American Thyroid Association Guidelines for Hyperthyroidism;Endocrine Practice;2019-07